Catalent Cell and Gene Content

1. Critical Path For Gene Therapy: AAV Analytical Lifecycle Considerations 12/2/2025

   Explore considerations for phase-appropriate AAV characterization and release activities from pre-clinical to late-phase products. Review validation challenges and paths for maturation of analytics.

2. Manufacturing Strategies To Industrialize Autologous Therapies 9/30/2025

   Discover how a systematic approach to autologous cell therapy manufacturing can reduce costs, improve reliability, and accelerate access to life-changing treatments.

3. Advanced iPSC Workflows: Accelerating Cell Therapy Development 9/30/2025

   Beyond offering our GMP-compliant iPS cells, we develop superior workflows for gene editing and differentiation to provide competitive platforms to our partners and accelerate their therapeutic programs.

4. Streamline AAV-Based Gene Therapies With Off-The-Shelf Plasmids 8/14/2025

   Standardized, well-characterized plasmids and streamlined platform processes can significantly accelerate viral vector development, improve consistency, and support scalable, high-quality gene therapy manufacturing.

5. UpTempo℠: Seamless Transitions From Bench To CGT Applications 6/19/2025

   Accelerate cell and gene therapy development with high-yield, regulatory-compliant plasmid DNA manufacturing that shortens timelines, minimizes risks, and streamlines your supply chain.

6. 07.14.23 -- Accelerate Development Timelines With Improved Characterization Methods 7/14/2023

   07/14/23 Cell & Gene Newsletter